HYPERTHERMIA has been shown to potentiate the action of some cytotoxic drugs (reviewed by and by Field & Bleehen (1979) ). The recent demonstration of the phenomenon of thermal tolerance (Gerner et al., 1976) led us to investigate the influence of thermal tolerance on sensitivity to 3 cytotoxic drugs.
Gerner et al. showed that by returning HeLa cells to 37°C after an initial thermal dose at 44°C their sensitivity to subsequent hyperthermic treatments is reduced. Direct evidence of the development of thermal tolerance during continuous exposure to hyperthermia (42-50C) has been described by Harisiadis et al. (1977) for CHO cells. Prolonged exposure at 42 5°C was also found to give considerable protection from subsequent exposure to acute hyperthermia at 45°C.
Preheating cells has also been shown to affect their reponse to cytotoxic agents. Hahn & Strande (1976) have shown the development of heat-induced resistance to adriamycin (ADR). CHO cells preheated * To wvhom correspon(lence should be addlressed.
for varying times at 43°C became progressively more resistant to subsequent ADR treatment at 43°C. However, over the times and drug concentrations used, preheat at 41°C did not appear to confer ADR resistance on the cells. Heat-induced resistance to actinomycin D has also been reported for CHO cells (Donaldson et al., 1978) . Exposures to 43°C with actinomycin D for more than 30 min, or preheating at 43TC before drug exposure, both reduced the cytotoxicity of actinomycin D.
In this study, the effect of preheating EMT6 cells in vitro on their subsequent response to cytotoxic agents at either 43°C or 37°C has been investigated.
MATERIALS AND METHODS
Cells. Full details of the EMT6/M/CC line have been given elsewhere (Twentyman & Bleehen, 1975) . Cells were grown and treated in 60ml glass medical flat bottles. Exponentially growing cultures in Eagle's medium supplemented with 2000 newborn calf serum were used 2 days after inoculation of 2 x 105 cells into the bottles in 5 ml of medium. Flasks wAere gassed writh 50o Co2 in air.
Some cells tended to float off from the monolayer during heat treatment. It was necessary to collect these for inclusion in the assay of cell survival, and the trypsinisation procedure was modified to permit this. Medium was transferred to a 30ml plastic universal container, the bottle was rinsed twice with 2-5 ml 0-1% trypsin, each rinsing being added to the medium in the universal. The combined medium and washings were centrifuged at 1000 rev/min (170 g) for 5 min while the bottle was incubated at 37°C for 15 min. The detached cells from the bottle were then resuspended in 1-5 ml growth medium and added to the pellet of collected floating cells. The cells were then counted using a haemocytometer and the cell-survival assay was continued as has been previously described.
Drugs.-The drugs used in this study were:
(1) 1.3 Bis -(2-chloroethyl -1 -nitrosourea) (BCNU) kindly supplied by the Drug Development Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute (Bethesda, Md) in 100mg vials. This was dissolved in 3 ml absolute alcohol and then further diluted as required in Hanks' balanced salt solution (HBSS) immediately before use in all cases.
(2) Bleomycin (BLM, Lundbeck) obtained as a freeze-dried 15mg plug. This was dissolved in HBSS, diluted to 2500 [kg/ml and stored at -20'C in small aliquots. Each aliquot was thawed at 37°C and further diluted with HBSS before use.
(3) Adriamycin (ADR: doxorubicin HCI, Pharmitalia) obtained as 10 mg freeze-dried powder with lactose. This was dissolved in HBSS, diluted to 250 ,ug/ml and stored at -20°C in small aliquots. Each was thawed at 37°C and further diluted with HBSS before use. All drugs were added to bottles in 0-2 ml IBSS.
Treatment details.-All heat treatments were effected by total immersion of the bottles in a circulating water bath with the temperature controlled to +01°C (Grant Ltd., U.K. The statistical method examines the difference between observed and expected surviving fractions on a logarithmic scale viz:
(log pj-log po) -(log qj -log qo). The method averages this difference over experiments and divides it by its standard error. The result has approximately a t-distribution under the Null Hypothesis and can be compared with tables of the distribution to obtain the probability (P) level. The values of P are showun in the text. The method of calculation of the appropriate standard error and degrees of freedom is available from the authors on request.
It is not thought helpful to showN, standarderror bars, as these wiould reflect interexperimental variations whereas the measurement pi/Po qjlqo is calculated for each experiment and averaged over experiments, thus eliminating interexperiment variation. were observed at preheat temperatures of 39TC, 41°C and 42°C. There was no evidence, however, for the induction of tolerance to subsequent exposure for 1 h at 430C for periods of up to 16 h preheat treatment at 38TC.
Thermal tolerance and drug cytotoxicity at elevated temperatures
When a lh exposure to 43°C, in the presence of a range of doses of either BCNU or BLM, was preceded by a 3h treatment at 40°C, heat-induced drug tolerance was seen (Figs 2a and b) .
Statistical analysis shows that for BCNU, at drug levels of 4-10 tg/ml,the observed cell survival for preheated cells was greater than expected (see Statistical Analysis) for non-preheated cells with P<001. For BLM, the difference was significant at all drug levels measured, with P<0-01. Under the same preheat conditions, however, for a lh exposure to 43°C plus ADR the result is concentration dependent, and amounts to an apparent progressive loss of thermal tolerance, but no heatinduced drug tolerance is found (Fig. 3) .
The statistical analysis of these data shows that at all drug concentrations greater than 0'01 ig/ml, the observed cell survival for preheated cells was less than the expected cell survival for non-preheated cells, P<0 01. The time-course and temperature dependence of pretreatment which leads to this effect have been studied: (a) Fig. 4 shows the effect of increasing times of preheat exposure at 4000 before 1 h treatment at 4300 with either 0-1 or 1.0 ,g/ml ADR. This demonstrates that 0.1 ,ug/ml ADR has very little influence on the development of heat-induced thermal tolerance, whereas 1.0 ,ug/ml at 43T0 after preheating appears to eliminate the thermal tolerance, i. Drug cytotoxicity at 370C has been studied after periods of preheat at either 400C or 43°C. Fig. 6 shows the dose reponse curves at 37°C for BCNU and ADR with and without preheat treatment of 3 h at 40°C. The data for these drugs, and also for BLM (not shown) shows that this preheat treatment has no effect on subsequent cytotoxicity at 37°C. Further work with ADR after preheat treatments at 390, 41°a nd 420C also showed no effect. At preheat temperatures above 42 5°C we observe different effects. Preheating for 1 h at 43°C sensitizes cells to subse- (1977) , although the conditions for its development are different. Some workers define thermal tolerance specifically as a reduction in the slope of the survival curve when cell survival is plotted against time at any raised temperature (Henle et al., 1 978) . However, in this series of experiments we are considering any evidence of protection against a subsequent treatment (whether thermal or otherwise) as heat-induced tolerance.
Using 3 h preheat at 40°C followed by a I h 43°C heat shock combined with either BCNU or BLM, tolerance to these drugs was seen. Donaldson et al. (1978) have demonstrated with CHO cells the development of heat-induced actinomycin D (AMD) tolerance after a minimum of 30 min heating at 43°C, for 0 5 ,ug/ml AMD. They found greater protection with longer heat exposures. Labelled drug studies excluded the possibilitv of a heat-induced reduction in intracellular AMD concentration mediated by membrane-permeability changes. Similarly, Hahn & Strande (1976) have shown for CHO cells tolerance to ADR at 43°C induced by preheat at 43°C for more than 50 min. They suggest that this may be explained by a reduced intracellular concentration of ADR. They show flowcytofluorimetric data illustrating that total cellular fluorescence of 2h preheated cells is less than that of non-preheated cells for an unstated ADR concentration. Similar studies in this laboratory (Chambers, unpublished) have confirmed this qualitative difference using 30 jug/ml ADR. However, at the much lower drug concentrations used in this present work there were no significant differences between levels in preheated and nonpreheated cells, within the limits of resolution of the method. Hahn & Strande (1976) Braun & Hahn (1975) under similar conditions. Preheating at 43°C prior to ADR treatment at 37°C, in contrast causes protection to ADR toxicity. This effect has also been noted by Li for CHO cells, but whereas they saw a progressive increase in protection with time at 37°C after preheat up to 7 h, in EMT6 we see maximum protection immediately after the preheating. This is maintained for 8 h, but is virtually eliminated by 12 h at 37°C after preheating.
Thus, we have demonstrated that preheating cells may affect their subsequent sensitivity to cytotoxic agents. The phenomena involved are complex and have been shown to be dependent on the drug used, its concentration and the temperature of the preheat exposure. For a particular drug, the different effects with the different preheat temperatures may reflect the results of Henle et al. (1 978) which show that heat induced thermal resistance differs qualitatively above and below about 43°C (the inflection point of the Arrhenius plot for thermal inactivation of mammalian cells). The mechanisms producing heat induced drug tolerance (or sensitization) remain to be elucidated, but may involve membrane events. Cellular heat injury, it has been suggested, results from changes in the cell membrane (Bowler et al., 1973) and membrane fluidity is known to affect permeability and transport systems in intact mycoplasma cells (McElhaney et al., 1973) . Alterations in membrane fluidity, causing disintegration of the integrity of the membrane, are thought to be involved in the hyperthermic cell death of E. coli (Yatvin, 1977) . Li & Hahn (1978) have shown that pretreatment of CHO cells with ethanol, which is known to modify membrane fluidity, induced resistance to subsequent heat or ADR exposures. The pattern of ethanol-induced tolerance was found to be very similar to that induced by prior heat exposure, suggesting that membrane fluidity may also be involved in heatinduced tolerance.
It is evident that increased understanding of hyperthermic effects on mammalian cell membranes is required before mechanisms for thermal tolerance are likely to be clearly elucidated. Further work is required to see whether similar phenomena occur in vivo and whether these interactions therefore need to be considered in the treatment of patients. Clearly, the differences already demonstrated between different drugs at varying concentrations and different temperatures indicate the uncertainties behind such therapeutic proposals at present.
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